cellular
entri
virus
repres
critic
area
studi
viral
tropism
also
viral
entri
dictat
natur
immun
respons
elicit
upon
infect
epidem
keratoconjunct
ekc
caus
virus
within
human
adenoviru
speci
hadvd
sever
ocular
surfac
infect
associ
corneal
inflamm
clathrinmedi
endocytosi
previous
shown
play
critic
role
entri
hadv
speci
mani
host
cell
type
howev
hadvd
endocytosi
corneal
cell
extens
studi
herein
show
essenti
role
cholesterol
rich
lipid
raft
microdomain
entri
primari
human
corneal
fibroblast
cholesterol
deplet
use
profoundli
reduc
viral
infect
replenish
solubl
cholesterol
effect
revers
allow
product
viral
infect
dna
identifi
rich
endosom
fraction
infect
src
kinas
activ
also
increas
rich
endosom
fraction
infect
src
phosphoryl
induct
decreas
cornea
compar
wild
type
mice
sirna
knock
corneal
cell
reduc
chemokin
induct
upon
viral
infect
cornea
show
reduc
cellular
entri
control
noncorn
pathogen
appear
util
caveolar
pathway
entri
cell
fail
infect
corneal
cell
entir
indic
viru
cell
specif
tropism
immunoelectron
microscopi
confirm
presenc
vesicl
earliest
stage
viral
entri
collect
experi
indic
first
time
use
lipid
raft
mediat
associ
pathway
entri
corneal
cell
connect
process
viral
entri
downstream
proinflammatori
cell
signal
human
adenovirus
hadv
caus
broad
rang
infect
mucos
site
addit
hadv
vector
wide
use
studi
cellular
process
chosen
gene
vaccin
deliveri
vehicl
clinic
use
shortcom
hadv
therapi
human
diseas
intrins
tendenc
infect
natur
occur
hadv
induc
innat
immun
respons
inflamm
one
potenti
mechan
hadv
induc
inflamm
found
process
viral
entri
cellular
compon
involv
viral
intern
directli
induc
subsequ
inflammatori
gene
express
infect
cell
therefor
understand
basic
mechan
hadv
induc
inflamm
mitig
complic
adenovir
gene
therapi
import
understand
mode
hadv
entri
variou
cell
type
endocytosi
multistep
process
involv
intern
macromolecul
particl
specif
transport
vesicl
deriv
cell
plasma
membran
clathrin
mediat
endocytosi
well
studi
endocyt
pathway
use
envelop
nonenvelop
virus
cell
surfac
abundantli
endow
compon
allow
detect
respons
extern
stimuli
lipid
raft
repres
one
major
constitu
cell
membran
contain
heterogen
popul
protein
act
center
downstream
cell
signal
caveola
special
type
lipid
raft
electron
microscopi
appear
uncoat
flaskshap
invagin
plasma
membran
respons
uptak
efflux
cholesterol
ester
caveolar
lipid
raft
mediat
endocytosi
play
import
role
cell
adhes
growth
caveolin
major
integr
membran
protein
caveola
includ
three
type
similar
molecular
weight
kda
found
cell
type
present
muscl
cell
knockout
gene
mice
also
reduc
express
lead
loss
morpholog
defin
caveola
caveolaelik
structur
identifi
possibl
pathway
viral
entri
howev
entri
via
caveola
recent
disput
addit
caveola
lipid
raft
implic
entri
filoviru
human
enteroviru
echoviru
human
immunodefici
viru
among
other
importantli
specif
mean
host
cell
entri
virus
appear
depend
type
cell
state
activ
may
redund
signal
molecul
integr
part
host
immun
respons
viral
infect
recent
studi
shown
role
cell
signal
viral
entri
viral
replic
adenovirus
viral
attach
specif
integrin
activ
turn
activ
small
gtpase
rac
inhibit
cell
signal
drastic
reduc
viru
infect
entri
regul
least
five
differ
kinas
viru
attach
cell
induc
lipid
raft
format
cluster
specif
surfac
protein
lipid
interestingli
mani
virus
bind
glycophosphatidylinositol
gpi
anchor
protein
gangliosid
associ
outer
leaflet
plasma
membran
may
lead
directli
activ
cellular
kinas
ad
increas
evid
viru
bind
lipid
raft
specif
initi
intracellular
signal
entri
adenovirus
exist
evid
suggest
entri
begin
requisit
bind
adenoviru
capsid
fiber
knob
cellular
receptor
coxsacki
adenoviru
receptor
car
particular
virus
caus
epidem
keratoconjunct
glycan
initi
bind
follow
secondari
interact
arginineglycineaspart
acid
rgd
motif
viral
capsid
penton
base
cellular
integrin
v
v
v
secondari
interact
thought
induc
host
cell
signal
cascad
result
clathrin
mediat
endocytosi
possibl
activ
depend
classic
endosom
pathway
herein
show
etiolog
agent
epidem
keratoconjunct
enter
primari
human
corneal
fibroblast
predominantli
via
lipid
raft
caveola
suggest
redund
cell
specif
mechan
adenovir
entri
test
whether
viral
entri
cell
andor
viru
specif
previous
shown
hadvc
directli
compar
pathway
infect
human
corneal
fibroblast
cell
use
individu
confoc
imag
slice
load
measur
coloc
pixel
amira
cell
green
late
endosom
marker
associ
convent
endosom
red
human
corneal
cell
coloc
greater
degre
cell
predominantli
coloc
indic
entri
pathway
caveola
figur
b
known
infect
cornea
fail
infect
corneal
cell
cultur
cell
coloc
predominantli
figur
b
cholera
toxin
b
subunit
ctxb
use
track
identifi
lipid
raft
examin
role
lipid
raft
microdomain
entri
treat
corneal
cell
viru
track
cellular
local
time
figur
coloc
viru
ctxb
observ
cell
membran
min
cytoplasm
min
perinuclear
region
min
support
role
lipid
raft
entri
corneal
cell
order
directli
determin
role
cholesterolladen
lipid
raft
entri
primari
corneal
cell
pretreat
mm
deplet
cholesterol
prior
infect
earlier
studi
show
essenti
role
integrin
src
kinas
hadv
entri
therefor
control
pretreat
also
includ
rgdcontain
design
match
amino
acid
sequenc
penton
base
davp
rgd
nyasaaea
order
block
integrin
aggreg
kgecontain
control
davp
kge
nyasaaea
otherwis
ident
rgd
chemic
use
inhibit
src
kinas
activ
min
hr
post
infect
viral
entri
appear
nearli
complet
block
pretreat
either
rgd
partial
kge
figur
replenish
cholesterol
hr
appear
restor
normal
cell
morpholog
viral
entri
assess
confoc
microscopi
figur
western
blot
analysi
deterg
free
lipid
raft
prepar
hr
post
infect
reveal
increas
lipid
raft
viru
infect
cell
judg
collect
fraction
figur
seen
much
lower
level
th
fraction
mock
infect
cell
cell
treat
prior
viru
infect
reduc
also
observ
increas
phosphosrc
psrc
viru
infect
cell
fraction
reduct
psrc
observ
rgd
pretreat
cell
wherea
pretreat
reduc
psrc
figur
result
suggest
relationship
src
entri
result
indic
cholesterol
deplet
corneal
cell
present
impedi
entri
past
cell
membran
investig
type
endosom
use
figur
use
enter
human
corneal
cell
human
corneal
cell
grown
slide
chamber
infect
red
cell
stain
antibodi
indic
follow
green
secondari
antibodi
origin
magnif
inset
repres
similarli
magnifi
squar
photomicrograph
b
three
random
frame
differ
experi
chosen
mask
fashion
experi
quantifi
coloc
use
amira
cell
coloc
predominantli
coloc
respect
corneal
cell
cc
coloc
predominantli
seen
student
test
use
comparison
c
human
corneal
cell
grown
chamber
slide
toxin
b
ctxb
ad
cell
ice
warm
incub
min
prior
confoc
microscopi
red
coloc
ctxb
green
time
point
min
warm
ctxb
coloc
observ
cell
membran
min
cytoplasm
min
perinuclear
region
infect
red
pretreat
prevent
viru
enter
cell
min
hr
post
infect
compar
pretreat
rgd
reduc
entri
compar
kge
treat
untreat
cell
costain
phalloidin
green
origin
magnif
inset
repres
similarli
magnifi
squar
photomicrograph
b
cholesterol
ad
pretreat
cell
one
hr
infect
confoc
microscopi
reveal
entri
virus
corneal
cell
c
deterg
free
lipid
raft
prepar
infect
corneal
cell
pretreat
rgd
kge
lyse
hr
post
infect
follow
immunoblot
phosphoryl
src
psrc
blot
show
increas
psrc
upon
viral
infect
reduc
express
cholesterol
deplet
block
integrin
aggreg
rgd
treatment
respect
treatment
effect
level
infect
cell
reduc
psrc
entri
flotat
gradient
fraction
post
nuclear
supernat
perform
separ
differ
endosom
compart
upon
viral
infect
fraction
maxim
express
indic
presenc
late
endosom
fraction
enrich
indic
presenc
caveola
figur
blot
strip
reprob
contain
fraction
found
also
contain
psrc
marker
earli
endosom
observ
fraction
upon
viral
infect
evid
fraction
express
psrc
confirm
src
activ
fraction
use
src
kinas
assay
substrat
fluoresc
kinas
activ
invers
proport
figur
result
suggest
pathway
mediat
involv
src
kinas
import
rout
hadv
entri
human
corneal
cell
pretreat
alter
fraction
result
reduc
identif
endosom
marker
figur
howev
exclud
altern
possibl
effect
clathrin
mediat
mechan
previous
shown
realtim
pcr
perform
amplifi
genom
nucleotid
sequenc
order
determin
presenc
viral
dna
differ
endosom
fraction
upon
infect
corneal
cell
significantli
viral
dna
present
fraction
contain
psrc
fraction
abund
figur
fraction
immunoblot
cav
psrc
b
src
kinas
assay
perform
endosom
fraction
assay
fluoresc
invers
proport
kinas
activ
shown
fraction
previous
show
increas
also
demonstr
greater
src
kinas
activ
c
fraction
maximum
express
subject
real
time
pcr
fraction
quantiti
viral
dna
reduc
pretreat
p
cholesterol
replenish
result
restor
express
p
differ
express
viru
infect
cell
pretreat
replenish
cholesterol
viru
infect
data
present
repres
four
experi
run
duplic
doi
fraction
vs
fraction
viru
infect
cell
pretreat
reduc
viral
dna
content
endosom
fraction
p
comparison
virus
often
circumv
artifici
barrier
cell
entri
use
altern
entri
pathway
howev
studi
pretreat
reduc
presenc
viral
dna
contain
fraction
contain
fraction
also
examin
presenc
viral
dna
lipid
raft
fraction
treat
cell
replenish
cholesterol
compar
treat
alon
prior
viral
infect
lipid
raft
fraction
treat
cholesterol
replenish
cell
content
equival
cell
treat
prior
infect
figur
critic
protein
caveola
upon
reduct
express
cell
lose
abil
form
caveola
prepar
sirna
oligo
realtim
pcr
reduc
express
corneal
cell
normal
figur
western
blot
analysi
sirna
transfect
also
show
reduct
protein
compar
untransfect
control
sirna
figur
specif
sirna
valid
show
express
unrel
protein
kinas
c
reduc
compar
control
data
shown
howev
infect
corneal
cell
knock
sirna
reduc
express
figur
use
mous
adenoviru
kerat
model
analyz
role
viral
infect
inject
corneal
stroma
mice
background
wild
type
control
confoc
microscopi
perform
min
hr
hr
post
infect
viral
entri
viral
attach
appear
markedli
reduc
compar
wild
type
mice
time
point
figur
western
blot
analysi
wild
type
cornea
infect
reveal
increas
psrc
wild
type
cornea
hr
post
infect
compar
mice
suggest
necessari
src
activ
infect
fig
similarli
upon
viral
infect
protein
express
reduc
mice
compar
wild
type
mice
figur
result
suggest
import
viral
entri
kinas
activ
subsequ
chemokin
express
src
kinas
previous
shown
critic
entri
inflammatori
consequ
infect
human
corneal
cell
data
present
suggest
src
may
play
import
role
lipid
raft
mediat
hadv
entri
corneal
cell
therefor
appli
src
kinas
inhibitor
mous
adenoviru
kerat
model
inject
min
prior
infect
reduc
corneal
inflamm
assess
histolog
day
post
infect
figur
also
reduc
express
elisa
hr
post
infect
p
figur
solvent
dmso
alon
reduc
inflamm
express
taken
togeth
data
suggest
enter
corneal
cell
least
part
via
caveola
integrin
depend
src
kinas
mediat
pathway
caveola
submicroscop
membran
associ
vesicl
found
abundantli
mammalian
cell
caveola
characterist
flask
bulbshap
appear
without
obviou
coat
clathrin
pit
initi
report
use
caveolar
pathway
enter
cell
later
observ
use
caveola
independ
pathway
caveola
contain
approxim
molecul
confirm
caveolin
associ
viral
entri
corneal
fibroblast
perform
ultrastructur
studi
without
viral
infect
figur
electron
micrograph
uninfect
fibroblast
demonstr
abund
membran
associ
vesicl
visibl
flask
shape
invagin
cell
membran
figur
within
hr
infect
virus
seen
caveolalik
structur
figur
tissu
section
appear
caveola
fuse
form
caveolar
vesicl
caveosom
report
earlier
virus
also
accumul
presum
caveosom
figur
order
confirm
membran
associ
vesicl
seen
ultrastructur
inde
caveola
appli
immunoelectron
microscopi
primari
antibodi
clathrin
secondari
antibodi
bound
proteina
nanogold
membraneassoci
vesicl
human
corneal
fibroblast
label
well
antibodi
figur
within
min
viral
adsorpt
mani
express
vesicl
seen
contain
viru
figur
size
contain
vesicl
corneal
cell
rang
diamet
data
shown
therefor
vesicl
appear
abl
accommod
nm
diamet
adenoviru
notabl
clathrin
stain
vesicl
cell
much
less
abund
clathrin
stain
vesicl
seen
contain
viru
data
shown
result
confirm
uptak
human
corneal
fibroblast
occur
vesicl
contain
endocytosi
use
pathogen
gateway
cellular
entri
specif
pathway
entri
seem
host
pathogen
specif
well
studi
mechan
receptormedi
entri
clathrindepend
endocytosi
previou
report
suggest
hadv
use
clathrin
mediat
endocytosi
cellular
entri
macropinocytosi
altern
pathway
caveola
ubiquit
surfac
cell
particularli
fibroblast
appear
larg
enough
accommod
human
adenovirus
typic
measur
nm
diamet
recent
hadvc
shown
util
lipid
raft
mediat
caveolar
endocytosi
non
fibroblast
cell
line
longstand
interest
pathogenesi
hadv
human
cornea
sought
test
viral
entri
primari
human
corneal
fibroblast
use
two
cell
type
primari
fibroblast
cultur
directli
human
donor
cornea
control
cell
human
alveolar
epitheli
cell
line
previous
shown
support
virion
product
commonli
use
cultur
hadv
result
clearli
demonstr
associ
entri
corneal
cell
highli
corneatrop
contrast
entri
cell
less
robust
appear
predominantli
involv
pathway
addit
control
also
test
entri
non
corneal
pathogen
degre
entri
human
corneal
cell
low
permit
quantit
analysi
caveola
mediat
entri
anoth
nonenvelop
dna
viru
controversi
absenc
still
success
enter
cell
suggest
redund
altern
mechan
howev
corneal
stromal
cell
appear
reli
larg
lipid
raft
mediat
associ
endocytosi
cholera
toxin
b
subunit
ctxb
shown
bind
glycosphingolipid
ligand
use
identifi
distinct
lipid
raft
endocyt
pathway
studi
ctxb
coloc
corneal
cell
entri
show
presenc
viral
dna
predominantli
associ
membran
fraction
import
acknowledg
clathrinmedi
endocytosi
also
sensit
acut
deplet
cholesterol
raft
recruit
shown
preced
clathrindepend
endocytosi
anthrax
toxin
egfr
bcr
respect
studi
cholesterol
deplet
also
reduc
viral
dna
rich
fraction
corneal
cell
indic
similar
redund
cholesterol
function
cholesterol
replenish
cell
treat
gain
entri
determin
confoc
microscopi
viral
dna
express
also
previous
show
critic
role
src
hadv
infect
observ
increas
src
kinas
activ
specif
enrich
fraction
infect
cell
strongli
suggest
role
caveosom
signal
upon
viral
infect
hr
post
infect
chemic
inhibitor
src
kinas
partial
reduc
viral
entri
wherea
rgd
complet
block
viral
entri
use
mous
kerat
model
show
reduc
entri
viru
compar
wild
type
mice
show
reduc
level
psrc
express
compliment
vitro
data
taken
togeth
find
suggest
role
src
kinas
caveosom
viral
entri
downstream
effect
chemokin
express
infect
cell
virus
even
within
viru
famili
util
differ
endocyt
pathway
may
extens
cross
talk
pathway
exampl
within
polyomavirus
jc
viru
enter
cell
via
clathrin
mediat
endocytosi
later
sort
caveosom
bk
viru
use
ph
depend
caveolar
endocytosi
polyomavirus
enter
cell
use
uncoat
vesicl
independ
caveolin
clathrin
studi
account
potenti
differ
cell
type
use
determin
viral
entri
ultrastructur
studi
confirm
associ
corneal
fibroblast
viral
entri
clathrin
cell
data
also
suggest
may
util
differ
entri
pathway
differ
cell
type
time
cours
studi
panel
cell
type
relev
corneal
infect
necessari
determin
rang
entri
mechan
util
better
understand
infecti
inflammatori
outcom
differ
entri
pathway
replic
readili
human
corneal
fibroblast
hand
knockdown
reduc
chemokin
express
suggest
caveolin
contribut
product
infect
corneal
inflamm
howev
data
may
relev
earliest
stage
infect
address
possibl
sort
viru
later
infect
differ
endosom
compart
summari
shown
enter
corneal
stromal
cell
via
associ
lipid
raft
specif
pathway
induc
caveosom
signal
express
proinflammatori
mediat
lipid
raft
mediat
endocytosi
may
prove
use
target
antivir
therapi
corneal
infect
anim
involv
studi
procur
maintain
use
accord
laboratori
anim
welfar
act
amend
nih
guid
care
use
laboratori
anim
nation
research
council
upon
approv
anim
care
committe
mass
eye
ear
infirmari
deriv
corneal
cell
deceas
human
donor
approv
massachusett
eye
ear
infirmari
human
studi
committe
conform
tenet
declar
helsinki
written
inform
consent
use
cornea
deceas
donor
famili
deem
unnecessari
human
studi
committe
corneal
tissu
arriv
without
identifi
data
tissu
found
eye
bank
unsuit
corneal
transplant
would
discard
use
research
primari
human
corneal
fibroblast
deriv
human
donor
cornea
previous
describ
cell
multipl
deceas
donor
multipl
eye
bank
pool
cell
monolay
use
passag
two
three
cell
hadv
use
studi
purchas
american
type
cultur
collect
atcc
manassa
va
viru
purif
perform
cesium
chlorid
gradient
viru
prepar
previous
describ
eight
wild
type
mice
obtain
jackson
laboratori
bar
harbor
experiment
infect
femal
mice
anesthet
intramuscular
inject
ketamin
mgkg
xylazin
mgkg
anesthet
drop
proparacain
hydrochlorid
alcon
fort
worth
tx
appli
topic
right
cornea
follow
inject
dmso
carrier
hour
one
viru
tissu
cultur
infect
dose
tcid
virusfre
dialysi
buffer
inject
central
corneal
stroma
glass
micropipett
needl
fit
gaspow
microinject
system
mdi
south
plainfield
nj
ophthalm
surgic
microscop
carl
zeiss
meditec
inc
thornwood
ny
day
post
infect
mice
euthan
use
co
inhal
prior
remov
cornea
histolog
cell
grown
slide
chamber
nunc
rochest
ny
treat
sigma
st
loui
mo
rgd
genscript
piscataway
nj
kge
genscript
piscataway
nj
calbiochem
la
jolla
ca
hr
infect
hadv
min
hr
cell
partial
fix
paraformaldehyd
min
wash
pb
contain
fb
permeabil
solut
contain
triton
min
min
block
fbspb
cell
incub
alexa
fluor
phalloidin
invitrogen
eugenia
min
room
temperatur
wash
three
time
pb
contain
fb
cell
fix
paraformaldehyd
mount
use
vectashield
vector
lab
burlingam
ca
mount
medium
contain
dapi
imag
taken
leica
confoc
microscop
use
glycerol
immers
object
mous
cornea
harvest
variou
time
point
inject
stain
alexa
fluor
phalloidin
invitrogen
fix
mount
use
vectashield
coloc
studi
infect
cell
fix
stain
antibodi
santa
cruz
biotechnolog
ca
santa
cruz
biotechnolog
invitrogen
individu
confoc
imag
stack
load
measur
coloc
pixel
amira
amira
burlington
cell
stain
green
red
three
frame
separ
experi
chosen
mask
fashion
use
gener
mean
standard
deviat
cell
treat
wash
thoroughli
infect
purifi
hadv
multipl
infect
moi
min
mock
treat
dialysi
buffer
infect
lr
fraction
isol
use
deterg
free
method
briefli
cell
wash
ice
cold
pb
suspend
na
co
lyse
stroke
prechil
dounc
homogen
disrupt
cell
membran
achiev
pass
lysat
gaug
needl
time
follow
cycl
sonic
subsequ
lysat
mix
equal
volum
sucrosemb
me
nmorpholinoethanesulfon
acid
plu
nacl
ph
overlaid
equival
volum
sucrosembsna
co
centrifug
hr
fraction
collect
protein
concentr
measur
lysat
immunoblot
antipsrc
cell
signal
danver
identifi
phosphoryl
src
lr
along
lr
marker
flotat
gradient
fraction
post
nuclear
supernat
perform
sucros
gradient
fraction
collect
one
hr
post
hadv
infect
pretreat
untreat
control
mock
infect
cell
collect
post
nuclear
supernat
prepar
use
nucbust
novagen
germani
post
nuclear
supernat
mix
equal
amount
sucros
layer
volum
sucros
volum
sucros
centrifug
hr
x
g
seri
fraction
collect
surfac
subject
western
blot
analysi
phosphoryl
src
santa
cruz
biotechnolog
realtim
pcr
gene
order
determin
presenc
viral
dna
endosom
sirna
control
scrambl
sirna
tabl
construct
use
scitool
integr
dna
technolog
idt
coralvil
ia
one
nm
transfect
use
lipofectamin
rnaimax
invitrogen
carlsbad
ca
follow
manufactur
instruct
hr
post
transfect
cell
infect
hadv
hr
analyz
messag
use
realtim
rtpcr
tabl
western
blot
analysi
protein
separ
gradient
gel
invitrogen
immunoblot
antibodi
actin
thermo
scientif
pittsburgh
pa
latter
intern
control
quantifi
presenc
viral
dna
endosom
compart
gene
amplifi
endosom
fraction
sucros
gradient
primer
idt
tabl
design
base
genom
nucleotid
sequenc
realtim
pcr
perform
fast
sybr
green
master
mix
appli
biosystem
foster
citi
ca
follow
condit
cycl
final
extens
min
determin
mrna
express
total
rna
extract
scrambl
sirna
transfect
infect
cell
hr
postinfect
use
trizol
invitrogen
accord
manufactur
instruct
total
rna
treat
dnase
unit
new
england
biolab
ipswich
two
dnase
treat
rna
subject
revers
transcript
mmlv
revers
transcriptas
promega
madison
wi
oligo
dt
primer
idt
primer
design
use
plu
softwar
http
synthes
idt
tabl
cdna
dilut
use
qrtpcr
use
fast
sybr
green
master
mix
condit
cycl
oat
min
final
extens
min
nontempl
control
endogen
control
human
gapdh
measur
rel
quantif
relat
express
level
calcul
method
untransfecteduninfect
control
src
activ
assay
perform
use
srcfamili
kinas
assay
promega
madison
wi
one
microgram
endosom
fraction
peptid
substrat
atp
ad
reaction
buffer
incub
min
room
temperatur
follow
addit
proteas
reagent
anoth
min
room
temperatur
reaction
stop
addit
stabil
reagent
kinas
activ
peptid
substrat
remain
nonphosphoryl
proteas
remov
amino
acid
peptid
substrat
liber
highli
mous
cornea
remov
hr
post
infect
n
group
cornea
homogen
pb
mm
phenylmethylsulfonyl
fluorid
pmsf
aprotinin
leupeptin
sigmaaldrich
st
loui
mo
lysat
centrifug
x
g
minut
supernat
use
elisa
mous
kc
r
system
minneapoli
mn
protein
detect
perform
commerci
avail
sandwich
elisa
kit
captur
detect
antibodi
accord
manufactur
instruct
sampl
standard
analyz
duplic
plate
read
micropl
reader
molecular
devic
sunnyval
ca
analyz
softmax
molecular
devic
upon
euthanasia
post
infect
mous
cornea
remov
surgic
rins
pb
fix
neutral
buffer
formalin
hr
room
temperatur
paraffin
embed
whole
eye
cut
section
mount
posit
charg
slide
air
dri
overnight
deparaffin
rehydr
slide
stain
hematoxylin
eosin
histolog
coverslip
photograph
axiovert
carl
zeiss
meditec
inc
use
object
human
corneal
fibroblast
plate
cm
dish
grown
confluenc
infect
cesium
chlorid
purifi
viru
moi
incub
min
c
follow
incub
c
min
cell
wash
pb
fix
paraformaldehyd
contain
gluteraldehyd
cacodyl
mm
cacl
hr
harvest
agaros
cell
pellet
fix
hr
aqueou
oso
dehydr
follow
dehydr
cell
pellet
embed
epon
section
nm
specimen
stain
satur
aqueou
uranyl
acet
sato
lead
stain
photomicrograph
taken
philip
electron
microscop
koninklijk
philip
electron
nv
amsterdam
netherland
oper
kv
fit
ccd
camera
immunostain
cell
adsorb
purifi
mock
infect
buffer
min
c
follow
incub
c
min
wash
pb
fix
paraformaldehyd
hr
harvest
cell
treat
sucros
pb
min
frozen
section
c
nm
thick
transfer
formvarcarbon
coat
copper
grid
grid
block
bsa
min
incub
min
rabbit
polyclon
antibodi
bd
bioscienc
san
jose
ca
bsa
follow
wash
pb
incub
proteina
nanogold
cell
microscopi
center
depart
cell
biolog
univers
medic
center
utrecht
netherland
particl
size
nm
min
altern
section
stain
mous
rais
rat
clathrin
heavi
chain
bd
bioscienc
follow
rabbit
antiserum
mous
igg
icn
biomed
irvin
ca
dilut
follow
proteina
nanogold
particl
size
nm
proteina
nanogold
incub
min
follow
wash
pb
final
wash
doubl
distil
water
grid
stain
uranyl
acet
methyl
cellulos
minut
photomicrograph
electron
microscop
comparison
mean
perform
anova
sheff
multipl
comparison
test
appropri
student
test
p
consid
statist
signific
